Skip Navigation

Cardiovascular Research 2001 49(4):808-816; doi:10.1016/S0008-6363(00)00311-4
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bianciotti, L. G.
Right arrow Articles by de Bold, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bianciotti, L. G.
Right arrow Articles by de Bold, A. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension

Liliana G. Bianciotti and Adolfo J. de Bold*

Cardiovascular Endocrinology Laboratory, University of Ottawa Heart Institute, Ottawa, Ont., Canada

* Corresponding author. Present address: Cardiac Cell and Molecular Biology Laboratory, University of Ottawa Heart Institute, 40 Ruskin St., H-247, Ottawa, Ont., Canada, K1Y 4W7. Tel.: +1-613-761-4265; fax: +1-613-761-1597

Objective: Increased expression of the cardiac natriuretic peptides (NP), atrial natriuretic factor (ANF) and brain natriuretic peptide (BNP) is observed during chronic hemodynamic overload. The mechanisms underlying this process are not fully understood. In vitro, endothelin 1 (ET-1) is a powerful stimulator of cardiac NP and, therefore, has been assumed to be one possible mediator of increased NP gene expression following chronic pressure or volume overload. In the present work we investigated the possible role of ET-1 in mediating the observed upregulation of cardiac NP in two kidney-one clip (2K-1C) Goldblatt hypertensive rats treated for 6 weeks with the ET-1 type A (ETA) receptor subtype receptor antagonist ABT-627. Methods: 2K-1C hypertension was induced in male Sprague–Dawley rats weighing 100–125 g by placing a silver clip (internal diameter 0.25 mm) around the left renal artery through a flank incision. The right kidney was left undisturbed. Sham operated rats underwent the same experimental procedures but no clip was placed on the left renal artery. ABT-627 was administered (10 mg/kg per day) in the drinking water for 6 weeks. Results: In hypertensive rats, ABT-627 prevented a further rise in blood pressure beginning at 3 weeks after clipping and reduced the ventricular hypertrophy observed at the end of the experiment. ETA blockade prevented enhanced NP gene expression in the right ventricle and partially prevented it in the left ventricle. No modifications in atrial NP gene expression were observed in either control or 2K-1C animals. ETA blockade decreased BNP circulating levels but did not affect ANF plasma levels in clipped rats. ABT-627 increased {alpha}-myosin heavy chain gene expression and decreased the abundance of the β isoform transcript. Conclusion: The results obtained in the present investigation show the participation of ET-1 in the increased expression of ventricular NP in 2K-1C renovascular hypertension and an apparent lack of effect of ETA blockade on atrial NP gene expression in both control and hypertensive animals thus showing that in vivo, atrial and ventricular NP gene expression are differentially regulated.

KEYWORDS Gene expression; Natriuretic peptide; Hypertension; Hypertrophy; Blood pressure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
H. Ruskoaho
Cardiac Hormones as Diagnostic Tools in Heart Failure
Endocr. Rev., June 1, 2003; 24(3): 341 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. G. Bianciotti and A. J. de Bold
Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor
Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1127 - H1134.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.